Interplay of matrix stiffness and c-SRC in hepatic fibrosis

Frontiers in Physiology

Volumn 6, Issue DEC, 2015, Pages

  Görtzen, Jan ^a   Schierwagen, Robert ^a   Bierwolf, Jeanette ^a   Klein, Sabine ^a   Uschner, Frank E ^a   van der Ven, Peter F ^a   Fürst, Dieter O ^a   Strassburg, Christian P ^a   Laleman, Wim ^b   Pollok, Jörg Matthias ^a   Trebicka, Jonel ^a,c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Hepatic stellate cells; Liver fibrosis; Matrix stiffness; PP2; RhoA; SRC

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ALBUMIN; CARBON TETRACHLORIDE; COLLAGEN TYPE 1; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE P60; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; THIOACETAMIDE;

ALBUMIN GENE; ALPHA SMA GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL ACTIVATION; CELL FUNCTION; COL1A1 GENE; COLLAGEN 1 GENE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; MATRIX STIFFNESS; NONHUMAN; PDGF R GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHOA GENE; RIGIDITY; STELLATE CELL; UPREGULATION; WESTERN BLOTTING;

EID: 84953223985     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00359     Document Type: Article

References (41)

1. Anadol, E., Schierwagen, R., Elfimova, N., Tack, K., Schwarze-Zander, C., Eischeid, H., et al. (2015). Circulating miRNAs as marker for liver injury in HIV patients. Hepatology 61, 46-55. doi: 10.1002/hep.27369
2. Beyer, C., and Distler, J. H. W. (2013). Tyrosine kinase signaling in fibrotic disorders: translation of basic research to human disease. Biochim. Biophys. Acta 1832, 897-904. doi: 10.1016/j.bbadis.2012.06.008
3. Brown, M. T., and Cooper, J. A. (1996). Regulation, substrates and functions of src. Biochim. Biophys. Acta 1287, 121-149.
4. Ceccherini, E., Indovina, P., Zamperini, C., Dreassi, E., Casini, N., Cutaia, O., et al. (2015). SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment. J. Cell. Biochem. 116, 856-863. doi: 10.1002/jcb.25042
5. Friedman, S. L. (2003). Liver fibrosis-from bench to bedside. J. Hepatol. 38(Suppl. 1), 38-53. doi: 10.1016/S0168-8278(02)00429-4
6. Gargalionis, A. N., Karamouzis, M. V., and Papavassiliou, A. G. (2014). The molecular rationale of Src inhibition in colorectal carcinomas. Int. J. Cancer 134, 2019-2029. doi: 10.1002/ijc.28299
7. Granzow, M., Schierwagen, R., Klein, S., Kowallick, B., Huss, S., Linhart, M., et al. (2014). Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis. Hepatology 60, 334-348. doi: 10.1002/hep.27117
8. Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., et al. (1996). Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271, 695-701.
9. Heller, J., Shiozawa, T., Trebicka, J., Hennenberg, M., Schepke, M., Neef, M., et al. (2003). Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats. Eur. J. Clin. Invest. 33, 1006-1012. doi: 10.1046/j.1365-2362.2003.01251.x
10. Hennenberg, M., Biecker, E., Trebicka, J., Jochem, K., Zhou, Q., Schmidt, M., et al. (2006). Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats. Gastroenterology 130, 838-854. doi: 10.1053/j.gastro.2005.11.029
11. Herman, B., Nieminen, A. L., Gores, G. J., and Lemasters, J. J. (1988). Irreversible injury in anoxic hepatocytes precipitated by an abrupt increase in plasma membrane permeability. FASEB J. 2, 146-151.
12. Huveneers, S., and Danen, E. H. J. (2009). Adhesion signaling-crosstalk between integrins, Src and Rho. J. Cell Sci. 122, 1059-1069. doi: 10.1242/jcs.039446
13. Karsdal, M. A., Manon-Jensen, T., Genovese, F., Kristensen, J. H., Nielsen, M. J., Sand, J. M. B., et al. (2015). Novel insights into the function and dynamics of extracellular matrix in liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 308, G807-G830. doi: 10.1152/ajpgi.00447.2014
14. Klein, S., Klösel, J., Schierwagen, R., Körner, C., Granzow, M., Huss, S., et al. (2012a). Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats. Lab. Invest. 92, 1440-1450. doi: 10.1038/labinvest.2012.106
15. Klein, S., Rick, J., Lehmann, J., Schierwagen, R., Schierwagen, I. G., Verbeke, L., et al. (2015). Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis. Gut 10:e0138732. doi: 10.1136/gutjnl-2015-309600
16. Klein, S., van Beuge, M. M., Granzow, M., Beljaars, L., Schierwagen, R., Kilic, S., et al. (2012b). HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects. J. Hepatol. 57, 1220-1227. doi: 10.1016/j.jhep.2012.07.033
17. Kwiecinski, M., Noetel, A., Elfimova, N., Trebicka, J., Schievenbusch, S., Strack, I., et al. (2011). Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. PLoS ONE 6:e24568. doi: 10.1371/journal.pone.0024568
18. Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., et al. (2013). Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat. Commun. 4, 2823. doi: 10.1038/ncomms3823
19. Musumeci, F., Schenone, S., Brullo, C., and Botta, M. (2012). An update on dual Src/Abl inhibitors. Future Med. Chem. 4, 799-822. doi: 10.4155/fmc.12.29
20. National Institute on Alcohol Abuse and Alcoholism (2014). Liver Cirrhosis Mortality in the United States: National, State, and Regional Trends, 2000-2011. Arlington, VA: CSR, Incorporated.
21. Nikitovic, D., Kouvidi, K., Karamanos, N. K., Tzanakakis, G. N., Nikitovic, D., Kouvidi, K., et al. (2013). The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression, the roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression. BioMed Res. Int. 2013:e929531. doi: 10.1155/2013/929531
22. Olsen, A. L., Bloomer, S. A., Chan, E. P., Gaça, M. D. A., Georges, P. C., Sackey, B., et al. (2011). Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G110-G118. doi: 10.1152/ajpgi.00412.2010
23. Quack, T., Knobloch, J., Beckmann, S., Vicogne, J., Dissous, C., and Grevelding, C. G. (2009). The formin-homology protein SmDia interacts with the Src kinase SmTK and the GTPase SmRho1 in the gonads of Schistosoma mansoni. PLoS ONE 4:e6998. doi: 10.1371/journal.pone.0006998
24. Rockey, D. (1997). The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 25, 2-5. doi: 10.1053/jhep.1997.v25.ajhep0250002
25. Sarang, Z., Köröskényi, K., Pallai, A., Duró, E., Melino, G., Griffin, M., et al. (2011). Transglutaminase 2 null macrophages respond to lipopolysaccharide stimulation by elevated proinflammatory cytokine production due to an enhanced avß3 integrin-induced Src tyrosine kinase signaling. Immunol. Lett. 138, 71-78. doi: 10.1016/j.imlet.2011.03.004
26. Takai, Y., Sasaki, T., and Matozaki, T. (2001). Small GTP-binding proteins. Physiol. Rev. 81, 153-208. doi: 10.1016/S0074-7696(08)61861-6
27. Thumkeo, D., Watanabe, S., and Narumiya, S. (2013). Physiological roles of Rho and Rho effectors in mammals. Eur. J. Cell Biol. 92, 303-315. doi: 10.1016/j.ejcb.2013.09.002
28. Trebicka, J., Anadol, E., Elfimova, N., Strack, I., Roggendorf, M., Viazov, S., et al. (2013). Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. J. Hepatol. 58, 234-239. doi: 10.1016/j.jhep.2012.10.015
29. Trebicka, J., Hennenberg, M., Laleman, W., Shelest, N., Biecker, E., Schepke, M., et al. (2007). Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase. Hepatology 46, 242-253. doi: 10.1002/hep.21673
30. Trebicka, J., Hennenberg, M., Odenthal, M., Shir, K., Klein, S., Granzow, M., et al. (2010). Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. J. Hepatol. 53, 702-712. doi: 10.1016/j.jhep.2010.04.025
31. Trebicka, J., Leifeld, L., Hennenberg, M., Biecker, E., Eckhardt, A., Fischer, N., et al. (2008). Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats. Hepatology 47, 1264-1276. doi: 10.1002/hep.22170
32. Varkaris, A., Katsiampoura, A. D., Araujo, J. C., Gallick, G. E., and Corn, P. G. (2014). Src signaling pathways in prostate cancer. Cancer Metastasis Rev. 33, 595-606. doi: 10.1007/s10555-013-9481-1
33. Verbeke, L., Farre, R., Trebicka, J., Komuta, M., Roskams, T., Klein, S., et al. (2014). Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. Hepatology 59, 2286-2298. doi: 10.1002/hep.26939
34. Wells, R. G. (2013). Tissue mechanics and fibrosis. Biochim. Biophys. Acta 1832, 884-890. doi: 10.1016/j.bbadis.2013.02.007
35. Wojtalla, A., Herweck, F., Granzow, M., Klein, S., Trebicka, J., Huss, S., et al. (2012). The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G873-G887. doi: 10.1152/ajpgi.00241.2011
36. World Health Organisation (2002). Reducing Risks, Promoting Healthy Life. Geneva: World Health Report.
37. Yamana, N., Arakawa, Y., Nishino, T., Kurokawa, K., Tanji, M., Itoh, R. E., et al. (2006). The Rho-mDia1 pathway regulates cell polarity and focal adhesion turnover in migrating cells through mobilizing Apc and c-Src. Mol. Cell. Biol. 26, 6844-6858. doi: 10.1128/MCB.00283-06
38. Yeatman, T. J. (2004). A renaissance for SRC. Nat. Rev. Cancer 4, 470-480. doi: 10.1038/nrc1366
39. Yokoi, K., Hawke, D., Oborn, C. J., Jang, J.-Y., Nishioka, Y., Fan, D., et al. (2011). Identification and validation of SRC and phospho-SRC family proteins in circulating mononuclear cells as novel biomarkers for pancreatic cancer. Transl. Oncol. 4, 83-91. doi: 10.1593/tlo.10202
40. Yoshizumi, M., Abe, J., Haendeler, J., Huang, Q., and Berk, B. C. (2000). Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J. Biol. Chem. 275, 11706-11712. doi: 10.1074/jbc.275.16.11706
41. Zhou, Q., Hennenberg, M., Trebicka, J., Jochem, K., Leifeld, L., Biecker, E., et al. (2006). Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut 55, 1296-1305. doi: 10.1136/gut.2005.081059